Literature DB >> 6110470

Effects of severe dopamine depletion on dopamine neuronal impulse flow and on tyrosine hydroxylase regulation.

D C German, B A McMillen, M K Sanghera, S I Saffer, P A Shore.   

Abstract

Reserpine depletes dopamine (DA) levels and increases tyrosine hydroxylase (TH) activity in the rat corpus striatum. TH is activated not only by enhancement of DA neuronal impulse flow, but also by cessation of impulse flow. To assist in the understanding of the relative contribution of impulse flow to the regulation of TH activity in the DA depleted neuron, we examined the consequences of severe DA depletion on substantia nigra DA neuronal impulse flow and on in vivo TH activity in the rat corpus striatum. One day after reserpine or 30 min after the reversible reserpine-like compound, Ro4-1284, striatal DA levels were severely depleted and in vivo TH activity was enhanced about three-fold. DA depletion was found to significantly increase DA neuronal impulse flow. Although the DA neuron is firing faster than normal in the DA depleted rat, because there is no DA being released it is still not clear whether the elevation in TH activity is due to the enhancement of impulse flow or to the lack of DA at presynaptic receptor sites, or both. gamma-Butyrolactone (GBL), causes a cessation of DA neuronal impulse flow and activates TH by a presynaptic autoreceptor mechanism. GBL inhibited by over 50 percent the elevation in TH activity produced by severe DA depletion. This finding suggests that the enhanced TH activation after DA depletion in in large part due to increased DA impulse flow. Furthermore, the TH activity seen with GBL in DA depleted rats was significantly less than that seen after GBL administration in normal rats. This finding is consistent with the hypothesis that the DA storage granule also plays a role in TH regulation.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6110470     DOI: 10.1016/s0361-9230(81)80037-8

Source DB:  PubMed          Journal:  Brain Res Bull        ISSN: 0361-9230            Impact factor:   4.077


  7 in total

1.  Deletion of Go2alpha abolishes cocaine-induced behavioral sensitization by disturbing the striatal dopamine system.

Authors:  Irene Brunk; Christian Blex; Carles Sanchis-Segura; Jan Sternberg; Stephanie Perreau-Lenz; Ainhoa Bilbao; Heide Hörtnagl; Jens Baron; Judyta Juranek; Gregor Laube; Lutz Birnbaumer; Rainer Spanagel; Gudrun Ahnert-Hilger
Journal:  FASEB J       Date:  2008-07-07       Impact factor: 5.191

2.  L-dopa infusion mode differentially affects corpus striatal dopamine efflux in the presence of reserpine.

Authors:  D E Dluzen; F T Kratko
Journal:  J Neural Transm Gen Sect       Date:  1992

3.  Exposure to the polybrominated diphenyl ether mixture DE-71 damages the nigrostriatal dopamine system: role of dopamine handling in neurotoxicity.

Authors:  Joshua M Bradner; Tiffany A Suragh; W Wyatt Wilson; Carlos R Lazo; Kristen A Stout; Hye Mi Kim; Min Z Wang; Douglas I Walker; Kurt D Pennell; Jason R Richardson; Gary W Miller; W Michael Caudle
Journal:  Exp Neurol       Date:  2012-12-31       Impact factor: 5.330

4.  Bromocriptine potentiates the behavioural effects of directly and indirectly acting dopamine receptor agonists in mice.

Authors:  O F Jenkins; D M Jackson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-10       Impact factor: 3.000

5.  Modulation by fenoldopam (SKF 82526) and bromocriptine of the electrically evoked release of vasopressin from the rat neurohypophysis. Effects of dopamine depletion.

Authors:  K Racké; J Meuresch; B Trapp; E Muscholl
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-04       Impact factor: 3.000

6.  Dose-dependent differences in the development of reserpine-induced oral dyskinesia in rats: support for a model of tardive dyskinesia.

Authors:  J L Neisewander; E Castañeda; D A Davis
Journal:  Psychopharmacology (Berl)       Date:  1994-09       Impact factor: 4.530

7.  Reduced vesicular storage of dopamine causes progressive nigrostriatal neurodegeneration.

Authors:  W Michael Caudle; Jason R Richardson; Min Z Wang; Tonya N Taylor; Thomas S Guillot; Alison L McCormack; Rebecca E Colebrooke; Donato A Di Monte; Piers C Emson; Gary W Miller
Journal:  J Neurosci       Date:  2007-07-25       Impact factor: 6.167

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.